Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65576 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Sunitinib N-Oxide ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide)
CAS:Lactams, nesoiFormula:C22H27FN4O3Color and Shape:Yellow Orange SolidMolecular weight:414.20672Dabigatran Etexilate Mesylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H41N7O5·CH4O3SColor and Shape:White Off-White Yellow PowderMolecular weight:723.30503Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C40H42N4O6Color and Shape:Off-White Light Brown SolidMolecular weight:674.31044Atazanavir Ethyl Analog (methyl ((6S,11S,12S,15S)-12-benzyl-6-(tert-butyl)-11-hydroxy-16,16-dimethyl-4,7,14-trioxo-9-(4-(pyridin-2-yl)benzyl)-3-oxa-5,8,9,13-tetraazaheptadecan-15-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C39H54N6O7Color and Shape:Off-White SolidMolecular weight:718.4054Darunavir System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:PowderErlotinib Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H23N3O4·HClColor and Shape:Pale Yellow PowderMolecular weight:429.14553Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormula:C17H15F3N2O3SColor and Shape:Yellow SolidMolecular weight:384.07555Nilotinib Related Compound C (3-Amino-4-methylbenzoic acid)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFormula:C8H9NO2Color and Shape:White Beige PowderMolecular weight:151.06333Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C24H35NO4Color and Shape:White Off-White SolidMolecular weight:401.25661Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C39H39N3O6Color and Shape:Off-White PowderMolecular weight:645.28389Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C27H29ClN4O5Color and Shape:Off-White PowderMolecular weight:524.18265Aminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C17H26F3N3O2·2HClColor and Shape:White PowderMolecular weight:433.15107R-Levetiracetam Hydroxybutyramide Analog ((R)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H16N2O3Color and Shape:White Off-White SolidMolecular weight:188.11609Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O6Color and Shape:Off-White SolidMolecular weight:674.37918Fluphenazine Decanoate N4-oxide
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C32H44F3N3O3SColor and Shape:Off-White PowderMolecular weight:607.30555Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C14H14O3Color and Shape:PowderMolecular weight:230.09429Refined Bleached Shellac
CAS:Natural gums, gum resins, resins and balsams nesoiColor and Shape:PowderPlerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White Off-White SolidAtazanavir S,R,S,S-diastereomer ((3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:White Off-White SolidMolecular weight:704.38975Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White SolidMolecular weight:381.07588Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:White Beige PowderMolecular weight:315.16569Apixaban
CAS:Lactams, nesoiFormula:C25H25N5O4Color and Shape:Off-White White SolidMolecular weight:459.19065Carvedilol
CAS:Cardiovascular drugs, nesoiFormula:C24H26N2O4Color and Shape:White Off-White Crystalline PowderMolecular weight:406.18926Alectinib Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C30H34N4O2·HClMolecular weight:482.26818Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS:Sulfonamides, nesoiFormula:C23H31N7O7SColor and Shape:White PowderMolecular weight:549.200574-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C17H21N·HClColor and Shape:White Off-White SolidMolecular weight:239.1674Sorafenib Diarylurea Analog (4,4'-[carbonylbis(azanediyl-4,1-phenyleneoxy)]bis(N-methylpyridine-2-carboxamide);N,N'-Bis{4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl}urea)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H24N6O5Color and Shape:White Off-White SolidMolecular weight:512.18082Ondansetron Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Off-White White PowderBupropion Hydrochloride Related Compound F (1-(3-chlorophenyl)-1-hydroxypropan-2-one)
CAS:Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormula:C9H9ClO2Color and Shape:Clear Yellow LiquidMolecular weight:184.02911Naproxen Related Compound L (1-(6-methoxynaphthalen-2-yl)ethanone)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C13H12O2Color and Shape:White Crystalline PowderMolecular weight:200.08373Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13FN6OColor and Shape:White PowderMolecular weight:288.11349Copovidone
CAS:Vinyl copolymers in primary forms, nesoiFormula:(C6H9NO)n(C4H6O2)mColor and Shape:White Yellow PowderMolecular weight:197.23 g/molErlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C25H29N3O5·HClColor and Shape:Off-White PowderMolecular weight:451.21072Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C19H23F3N2O5Color and Shape:Off-White SolidMolecular weight:416.15591Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C15H16O3Color and Shape:White Crystalline PowderMolecular weight:244.10994Ezetimibe
CAS:Lactams, nesoiFormula:C24H21F2NO3Color and Shape:White PowderMolecular weight:409.14895Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C21H26F2O5Color and Shape:White Light Yellow Crystalline SolidMolecular weight:396.17483Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H15ClN2O2Color and Shape:White Off-White CrystalsMolecular weight:206.08221Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White SolidMolecular weight:297.11874Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C20H22N2O6SColor and Shape:Yellow PowderMolecular weight:418.11986Plerixafor
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C28H54N8Color and Shape:White Off-White PowderMolecular weight:502.44714Paroxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClH2OColor and Shape:White Off-White Crystalline PowderMolecular weight:329.142722,4-Disulfamyl-5-Trifluoromethylaniline
CAS:Sulfonamides, nesoiFormula:C7H8F3N3O4S2Color and Shape:PowderMolecular weight:318.99083Desethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C23H25I2NO3·HClColor and Shape:White Off-White SolidMolecular weight:652.96907Carvedilol Related Compound E (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO2Color and Shape:Off-White PowderMolecular weight:167.09463Gefitinib Related Compound A (7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H21N3O4Color and Shape:White Yellow PowderMolecular weight:319.15321Prasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H20FNO3S·HClColor and Shape:White Off-White PowderMolecular weight:409.09147Nilotinib Related Compound A (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C11H10F3N3Color and Shape:Beige PowderMolecular weight:241.08268Methylparaben
CAS:Carboxylic acids with phenol function but without otherFormula:C8H8O3Color and Shape:White Crystalline PowderMolecular weight:152.15Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C13H19NO3·HClColor and Shape:White PowderMolecular weight:237.13649
![Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1098526.webp&w=3840&q=75)
